People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, ...

Novo Nordisk AS and a group of insurers will pay $32 million to end litigation over its $1.8 billion acquisition of ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term ...

Blockbuster weight-loss shots like Ozempic, Wegovy and Victoza may have an unexpected side effect impacting as many as ...

Intermittent fasting refers to a diet in which people reduce the number of hours they eat in a day. Benefits to this strategy ...

Wegovy, a weight loss drug made famous by celebrities around the world, is on New Zealand pharmacists' shelves, but it is ...

WEIGHT-LOSS drugs that last week became available on the NHS will not be available through Jersey’s publicly funded healthcare system for treating obesity until September at the earliest. A government ...

Erdem Hospital in Istanbul has announced the launch of a new pre-operative education program tailored specifically for ...

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

China has approved a new weight-loss drug that is poised to rival Novo Nordisk and Eli Lilly's popular GLP-1 treatments, ...

Across our campus and throughout our nearly 400 years, Harvard innovation—in medicine, technology, education, and beyond—has made Americans’ lives easier, healthier, and safer. While working at ...